Research Article
Analysis of the Molecular Mechanism of Acute Coronary Syndrome Based on circRNA-miRNA Network Regulation
Table 1
Patients characteristics (
group
= 5).
| | CG | UAP | AMI |
| Age (years) | 55 ± 11 | 60 ± 11 | 54 ± 8 | HR (min) | 66 ± 9 | 71 ± 13 | 81 ± 10 | SBP (mmHg) | 149 ± 10 | 146 ± 11 | 130 ± 15 | DBP (mmHg) | 83 ± 12 | 79 ± 16 | 75 ± 6 | Glu (3.9–6.1 mmol/L) | 5.25 ± 7.82 | 5.34 ± 0.62 | 6.46 ± 1.92 | CHO (0–5.2 mmol/L) | 3.69 ± 0.88 | 3.99 ± 1.05 | 3.81 ± 0.37 | TG (0.7–1.7 mmol/L) | 1.26 ± 0.65 | 1.21 ± 0.41 | 1.27 ± 0.45 | APOA1 (1–1.76 g/L) | 1.13 ± 0.20 | 1.00 ± 0.10 | 0.89 ± 0.12 | APOB (0.6–1.14 g/L) | 0.72 ± 0.20 | 0.79 ± 1.84 | 0.71 ± 0.15 | HDL (0.8–1.55 mmol/L) | 1.11 ± 0.18 | 0.92 ± 0.20 | 0.95 ± 0.12 | LDL(1.64–3.62 mmol/L) | 2.25 ± 0.66 | 2.54 ± 0.92 | 2.52 ± 0.44 | AST (15–50 U/L) | 21.60 ± 4.98 | 25.60 ± 4.22 | 96.80 ± 65.06 | LDH (313–618 U/L) | 149.20 ± 17.20 | 162.60 ± 29.59 | 449.00 ± 265.70 | CK (55–170 U/L) | 48.00 ± 13.21 | 70.80 ± 35.09 | 817.60 ± 535.16 | CK-MB (0–25 U/L) | 15.80 ± 7.22 | 16.80 ± 4.23 | 74.40 ± 48.55 | Gensini score (%) | 1.00 ± 1.41 | 65.40 ± 49.09 | 51.90 ± 10.37 |
|
|
APOA1 = apolipoprotein A1; APOB = apolipoprotein B; CHO = total cholesterol; HDL = high-density lipoprotein; LDL = low-density lipoprotein; AST = aspartate transaminase; LDH = lactate dehydrogenase; CK = creatine kinase; CK-MB = creatine kinase isoenzyme MB.
|